Antibody: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
[[IgG Branco]]<br /> | [[IgG Branco]]<br /> | ||
[[Monoclonal Antibody]].<br /> | [[Monoclonal Antibody]].<br /> | ||
For Anti-HIV | For Anti-HIV-1 antibodies see [[Human Fab PG16]] and [[VRC01 gp120 complex|VRC01 and VRC01-like antibodies are important in neutralizing HIV-1]]<br /> | ||
For Anti-VEGF Fab see [[Bevacizumab]] (Avastin)<br /> | For Anti-VEGF Fab see [[Bevacizumab]] (Avastin)<br /> | ||
For Anti-factor IX Fab see [[Conformation-specific anti-Factor IX antibodies]]<br /> | For Anti-factor IX Fab see [[Conformation-specific anti-Factor IX antibodies]]<br /> | ||